Lpath Company Profile (NASDAQ:LPTN)

About Lpath

Lpath logoLpath, Inc. is a biotechnology company. The Company is focused on the discovery and development of lipidomic-based therapeutic antibodies. The Company's product candidates include iSONEP, ASONEP and Lpathomab. The Company utilizes ImmuneY2 technology for the production of its antibodies. iSONEP is the ocular formulation of sonepcizumab, a monoclonal antibody (mAb) against sphingosine-1-phosphate (S1P). ASONEP is the systemic formulation of sonepcizuma, an mAb against the bioactive lipid S1P, a validated angiogenic factor and validated mediator of lymphocyte trafficking. ASONEP is indicated for various tumor types. Lpathomab is a humanized mAb against lysophosphatidic acid (LPA), a tumorigenic and metastatic agent and a validated contributor to neuropathic pain and traumatic brain injury. The product is indicated for the treatment of neuropathic pain, chemo-induced pain, traumatic brain injury and fibrosis. It has completed dosing in Phase Ia clinical trial in healthy volunteers.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: LPTN
  • CUSIP:
Key Metrics:
  • Previous Close: $3.57
  • 50 Day Moving Average: $2.66
  • 200 Day Moving Average: $2.56
  • 52-Week Range: $1.68 - $5.88
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -17.85
  • P/E Growth: 0.00
  • Market Cap: $8.48M
  • Outstanding Shares: 2,374,000
  • Beta: 0.49
Profitability:
  • Net Margins: -20,852.27%
  • Return on Equity: -97.30%
  • Return on Assets: -86.09%
Debt:
  • Current Ratio: 6.60%
  • Quick Ratio: 6.60%
Additional Links:
Companies Related to Lpath:

Analyst Ratings

Consensus Ratings for Lpath (NASDAQ:LPTN) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: $2.45 (31.37% downside)

Analysts' Ratings History for Lpath (NASDAQ:LPTN)
Show:
DateFirmActionRatingPrice TargetDetails
8/19/2016S&P Equity ResearchLower Price Target$3.15 -> $2.45View Rating Details
3/12/2015MLV & Co.Reiterated RatingBuy$11.00View Rating Details
(Data available from 9/27/2014 forward)

Earnings

Earnings History for Lpath (NASDAQ:LPTN)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Lpath (NASDAQ:LPTN)
Current Year EPS Consensus Estimate: $2.03 EPS
Next Year EPS Consensus Estimate: $-0.20 EPS

Dividends

Dividend History for Lpath (NASDAQ:LPTN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Lpath (NASDAQ:LPTN)
Insider Ownership Percentage: 4.50%
Institutional Ownership Percentage: 2.15%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/12/2014Daniel H PetreeDirectorBuy10,000$2.79$27,900.00View SEC Filing  
8/20/2014Gary J G AtkinsonCFOBuy5,000$3.10$15,500.00View SEC Filing  
8/19/2014Scott R PancoastCEOBuy10,000$3.00$30,000.00View SEC Filing  
8/18/2014Scott R PancoastCEOBuy10,000$3.22$32,200.00View SEC Filing  
12/19/2012Charles MathewsDirectorBuy5,000$4.98$24,900.00View SEC Filing  
12/18/2012Scott R PancoastCEOBuy5,000$4.95$24,750.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Lpath (NASDAQ:LPTN)
DateHeadline
biz.yahoo.com logoLPATH, INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:LPTN)
biz.yahoo.com - September 14 at 10:13 AM
News IconApollo Endosurgery, Lpath ink reverse merger (NASDAQ:LPTN)
www.massdevice.com - September 10 at 5:29 PM
News IconLpath (LPTN) Stock Gains on Acquisition News (NASDAQ:LPTN)
www.modestmoney.com - September 10 at 5:29 PM
News IconVC-backed Apollo Endosurgery and Lpath to merge (NASDAQ:LPTN)
www.pehub.com - September 8 at 5:49 PM
streetinsider.com logoApollo Endosurgery to Acquire Lpath (LPTN) (NASDAQ:LPTN)
www.streetinsider.com - September 8 at 5:49 PM
biz.yahoo.com logoLPATH, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Impairments, Amendments to Articl (NASDAQ:LPTN)
biz.yahoo.com - September 8 at 5:49 PM
publicnow.com logoApollo Endosurgery and Lpath Sign Merger Agreement (NASDAQ:LPTN)
www.publicnow.com - September 8 at 5:49 PM
baystreet.ca logoBiotech Companies With Huge Potential (NASDAQ:LPTN)
www.baystreet.ca - August 31 at 10:49 AM
News IconBiotech Firm Eyeing First in Man Studies (NASDAQ:LPTN)
www.ssuchronicle.com - August 31 at 10:49 AM
News IconBuy This Top Penny Stock Now Before It Rebounds 446% (NASDAQ:LPTN)
moneymorning.com - August 25 at 5:58 PM
capitalcube.com logoLpath, Inc. :LPTN-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 (NASDAQ:LPTN)
www.capitalcube.com - August 12 at 6:06 PM
biz.yahoo.com logoLPATH, INC Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:LPTN)
biz.yahoo.com - July 18 at 4:46 PM
News IconLpath Awarded Department of Defense Grant for Traumatic Brain Injury Pain Study (NASDAQ:LPTN)
www.medindia.net - June 22 at 10:42 AM
marketwatch.com logoLpath’s stock blasts off after government grant awarded (NASDAQ:LPTN)
www.marketwatch.com - June 21 at 10:29 AM
News IconLpath (LPTN) Shares Sent Sky-High by DoD Grant (NASDAQ:LPTN)
www.economiccalendar.com - June 21 at 10:29 AM
rttnews.com logoLpath Inc. (LPTN) Leaped After Government Grant (NASDAQ:LPTN)
www.rttnews.com - June 21 at 10:29 AM
finance.yahoo.com logoWhy is Lpath (LPTN) Stock Skyrocketing Today? (NASDAQ:LPTN)
finance.yahoo.com - June 20 at 2:53 PM
biz.yahoo.com logoSplits Calendar: Lpath splits before market open today (1:14 ratio) (NASDAQ:LPTN)
biz.yahoo.com - June 13 at 7:03 AM
nasdaq.com logoMRK Opens Wallet, VRX To Face FDA Panel In July, SPHS Vaults On Trial Data (NASDAQ:LPTN)
www.nasdaq.com - June 10 at 8:55 AM
streetinsider.com logoLpath (LPTN) Approves 1-for-14 Reverse Stock Split (NASDAQ:LPTN)
www.streetinsider.com - June 10 at 8:55 AM
biz.yahoo.com logoLPATH, INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters (NASDAQ:LPTN)
biz.yahoo.com - June 9 at 4:11 PM
finance.yahoo.com logoLpath Reveals 1-For-14 Reverse Stock Split (NASDAQ:LPTN)
finance.yahoo.com - June 9 at 10:17 AM
publicnow.com logoLpath Announces 1-for-14 Reverse Stock Split (NASDAQ:LPTN)
www.publicnow.com - June 9 at 8:29 AM
capitalcube.com logoLpath, Inc. :LPTN-US: Earnings Analysis: Q1, 2016 By the Numbers : May 26, 2016 (NASDAQ:LPTN)
www.capitalcube.com - May 26 at 11:14 AM
streetupdates.com logoCurrent Analysts Rating Update: Cigna Corporation (NYSE:CI) , Lpath, Inc. (NASDAQ:LPTN) - Street Updates (NASDAQ:LPTN)
www.streetupdates.com - May 24 at 8:15 PM
News IconLpath, Inc. (LPTN) Updated Broker Price Targets - Share Trading News (NASDAQ:LPTN)
www.sharetrading.news - May 20 at 8:00 PM
isstories.com logoThe Stock with Worst Weekly Performance: Lpath Inc.'s (LPTN) - Is stories (NASDAQ:LPTN)
www.isstories.com - May 19 at 8:01 PM
streetupdates.com logoHave a look at Price Moves: Lpath, Inc. (NASDAQ:LPTN) , Apricus Biosciences, Inc (NASDAQ:APRI) - Street Updates (NASDAQ:LPTN)
www.streetupdates.com - May 13 at 8:26 PM
News IconAfter Last Week What Do Analysts Think Of Lpath, Inc. (LPTN) - Share Trading News (NASDAQ:LPTN)
www.sharetrading.news - May 8 at 10:19 PM
News IconBroker Outlook For Lpath, Inc. (LPTN) - Share Trading.News - Share Trading News (NASDAQ:LPTN)
www.sharetrading.news - May 6 at 8:47 PM
News IconHot Biotech Stocks Recap: Relypsa, Inc. (NASDAQ:RLYP), Lpath Inc. (NASDAQ:LPTN) - Street Register (NASDAQ:LPTN)
streetregister.com - May 5 at 9:27 PM
News IconBiotech Stocks Worth a Closer Look: Lpath Inc. (NASDAQ:LPTN), ImmunoGen, Inc. (NASDAQ:IMGN) - Street Register (NASDAQ:LPTN)
streetregister.com - May 4 at 8:27 PM
isstories.com logoBiotech Movers: Baxalta Incorporated (NYSE:BXLT) , Lpath, Inc. (NASDAQ:LPTN) - Is stories (NASDAQ:LPTN)
www.isstories.com - May 4 at 8:27 PM
News IconTuesday's Mid-Day Stock Update: Fairway Group Holdings (FWM), Lpath Inc (LPTN), Northwest Biotherapeutics ... - Analyst Ratings (NASDAQ:LPTN)
www.analystratings.com - May 4 at 1:29 AM
News IconIntraday Active Biotech Stocks News: Sarepta Therapeutics, Inc. (NASDAQ:SRPT), Lpath Inc. (NASDAQ:LPTN) - Street Register (NASDAQ:LPTN)
streetregister.com - May 3 at 8:20 PM
News IconStocks to Watch: Resolute Energy Corp (REN), Lpath, Inc. (LPTN) - News Oracle (NASDAQ:LPTN)
www.newsoracle.com - April 29 at 9:00 PM
News IconThese Healthcare Stocks are Trending: Lpath (LPTN), Novavax (NVAX) - News Oracle (NASDAQ:LPTN)
www.newsoracle.com - April 28 at 9:56 PM
News IconBroker Roundup For Lpath, Inc. (LPTN) - Share Trading News (NASDAQ:LPTN)
www.sharetrading.news - April 28 at 9:55 PM
kcregister.com logoTrending Tickers: Lpath Inc. (NASDAQ:LPTN), Blueprint Medicines Corporation (NASDAQ:BPMC), Sterling Bancorp ... - KC Register (NASDAQ:LPTN)
www.kcregister.com - April 27 at 9:23 PM
istreetwire.com logoStocks Highlights: Lpath Inc. (LPTN), Starbucks Corporation (SBUX), Comcast Corporation (CMCSA) - iStreetWire (NASDAQ:LPTN)
www.istreetwire.com - April 27 at 9:23 PM
News IconWednesday's Mid-Day Movers: StemCells Inc (STEM), Lpath Inc (LPTN), Gastar Exploration (GST), Repros ... - Analyst Ratings (NASDAQ:LPTN)
www.analystratings.com - April 27 at 9:23 PM
streetupdates.com logoPrice Fluctuations to Observe: Lpath, Inc. (NASDAQ:LPTN) , Celldex Therapeutics, Inc. (NASDAQ:CLDX) - Street Updates (NASDAQ:LPTN)
www.streetupdates.com - April 27 at 9:23 PM
News IconSuspected herdsmen kill 5 in Enugu (NASDAQ:LPTN)
sacredheartspectrum.com - April 27 at 3:38 AM
finance.yahoo.com logoLPATH, INC Financials (NASDAQ:LPTN)
finance.yahoo.com - March 26 at 1:04 PM
capitalcube.com logoLpath, Inc. :LPTN-US: Earnings Analysis: Q4, 2015 By the Numbers (NASDAQ:LPTN)
www.capitalcube.com - March 25 at 11:50 AM
capitalcube.com logoLpath, Inc. :LPTN-US: Earnings Analysis: 2015 By the Numbers (NASDAQ:LPTN)
www.capitalcube.com - March 25 at 11:20 AM
biz.yahoo.com logoLPATH, INC Files SEC form 10-K, Annual Report (NASDAQ:LPTN)
biz.yahoo.com - March 22 at 5:09 PM
publicnow.com logoLpath Completes Dosing in the Lpathomab Phase 1 Safety Study (NASDAQ:LPTN)
www.publicnow.com - February 1 at 8:10 AM
biz.yahoo.com logoLPATH, INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transf (NASDAQ:LPTN)
biz.yahoo.com - January 6 at 4:17 PM
noodls.com logoLpath to Hold Corporate Update Conference Call and Live Webcast on Tuesday, November 17th (NASDAQ:LPTN)
www.noodls.com - November 16 at 8:35 AM

Social

Lpath (NASDAQ:LPTN) Chart for Tuesday, September, 27, 2016


Last Updated on 9/27/2016 by MarketBeat.com Staff